Iontcho Vlahov
Corporate Officer/Principal at ENDOCYTE, INC.
Profile
Iontcho Vlahov is a professional with a doctorate degree from Ruhr-Universität Bochum.
He is currently the Vice President-Discovery Chemistry at Endocyte, Inc. He has previously worked as a Scientist at Hercules, Inc., Head-Discovery Chemistry at IVAX LLC, Research Associate at the University of Iowa, Senior Research Scientist at Universität Konstanz, and Research Scientist at Bulgarian Academy of the Sciences and Institute of Organic Chemistry & Biochemistry AS CR v.v.i.
Iontcho Vlahov active positions
| Companies | Position | Start |
|---|---|---|
| ENDOCYTE, INC. | Corporate Officer/Principal | 2011-07-18 |
Former positions of Iontcho Vlahov
| Companies | Position | End |
|---|---|---|
| Bulgarian Academy of the Sciences | Corporate Officer/Principal | - |
| Institute of Organic Chemistry & Biochemistry AS CR v.v.i | Corporate Officer/Principal | - |
| University of Iowa | Corporate Officer/Principal | - |
| Universität Konstanz | Corporate Officer/Principal | - |
Hercules, Inc.
 Hercules, Inc. Chemicals: Major DiversifiedProcess Industries Hercules, Inc. used to manufacture and market specialty chemicals. It operated through two segments, Performance Products segment and Additives segment. The company was founded in 1912 and was headquartered in Wilmington, DE. | Corporate Officer/Principal | - |
Training of Iontcho Vlahov
| Ruhr-Universität Bochum | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Hercules, Inc.
Hercules, Inc. Chemicals: Major DiversifiedProcess Industries Hercules, Inc. used to manufacture and market specialty chemicals. It operated through two segments, Performance Products segment and Additives segment. The company was founded in 1912 and was headquartered in Wilmington, DE. | Process Industries |
IVAX LLC
 IVAX LLC Pharmaceuticals: MajorHealth Technology IVAX LLC discovers, develops, manufactures, and markets generic pharmaceuticals, respiratory drugs, and cancer treatments. It offers drugs for the treatment of multiple sclerosis, brain cancer, asthma, and epilepsy. The company was founded by Phillip Frost and Jane H. Hsiao in 1987 and is headquartered in Weston, FL. | Health Technology |
Endocyte, Inc.
 Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN. | Health Technology |
| Institute of Organic Chemistry & Biochemistry AS CR v.v.i |
- Stock Market
- Insiders
- Iontcho Vlahov
